• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危人群中的糖尿病视网膜病变筛查:分布成本效益分析方案

Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis.

作者信息

Stanimirovic Aleksandra, Francis Troy, Meerai Sonia, Mathew Suja, Ibrahim Sarah, Bowen James M, PIkula Aleksandra, Rac Valeria

机构信息

Toronto General Hospital Research Institute, Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.

Institute of Health Policy, Management and Evaluation, University of Toronto, Dalla Lana School of Public Health, Toronto, ON, Canada.

出版信息

JMIR Res Protoc. 2025 Apr 30;14:e60488. doi: 10.2196/60488.

DOI:10.2196/60488
PMID:40305086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079062/
Abstract

BACKGROUND

Diabetic retinopathy (DR) remains the primary vision complication of diabetes and the leading cause of blindness among adults, with up to 30% prevalence among low-income populations. Tele-retina is a cost-effective screening alternative to vision loss prevention, yet there is an adverse association between screening and income. Intersectionality theory notes that barriers to achieving health equity result from the intersection of personal and social characteristics. Experiences at this intersection are influenced by interpersonal and structural systems of oppression. Studies have found that tele-retina is the preferred strategy over standard of care screening for at-risk populations. No study has assessed the economic equity impact of DR screening using a theoretical foundation.

OBJECTIVE

This study aims to address shortcomings related to the utilization of intersectionality theory in the economic evaluation of DR screening. We propose conducting a distributional cost-effectiveness analysis (DCEA) of the tele-retina program.

METHODS

The study will be undertaken using a deductive theoretical drive sequential multimethod approach, consisting of two studies: (1) a modified Delphi study and (2) DCEA. The Delphi panel (patient partners, field experts, and decision makers; N=35-50) will select the social constructs (eg, age, gender) for at-risk populations and potential trade-offs between health maximization and equity. The research will be guided by a social theory framework (intersectionality theory) to understand the impact of social constructs on economic outcomes. Social constructs that are selected by the Delphi panel will be integrated into the validated tele-retina cost-effectiveness analysis model, which will serve as a case study for DCEA.

RESULTS

We have submitted the research ethics board application to the University Health Network Research Ethics Board and are expecting to begin recruitment for the Delphi study in Spring 2025. We anticipate beginning work on the model in the summer of 2025 and completing it by early 2026.

CONCLUSIONS

The Delphi study will provide an understanding of which social factors are deemed necessary by the stakeholders for guiding the inequity in care access. Study results will offer information related to the net health benefit of the intervention and the health equity impact of the tele-retina program, hence providing a more comprehensive valuation of the tele-retina program, which is informative to policy makers and governments whose goal is to mitigate the drivers of health inequities. We anticipate that each of these drivers will raise important questions regarding the implications for decision-making that may have not yet been addressed by Canadian health technology assessment bodies, such as the Canada Drug Agency. This is the first Canadian study to (1) have social constructs for DCEA selected by the Delphi panel, (2) mainstream how health equity framework and social constructs are used in economic assessment, (3) improve DR screening programs by using health equity lens, and (4) scale and adopt "de-novo" integration of social constructs in economic models for program evaluation.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/60488.

摘要

背景

糖尿病视网膜病变(DR)仍然是糖尿病的主要视力并发症,也是成年人失明的主要原因,在低收入人群中的患病率高达30%。远程视网膜筛查是一种具有成本效益的预防视力丧失的筛查方法,但筛查与收入之间存在不利关联。交叉性理论指出,实现健康公平的障碍源于个人和社会特征的交叉。在这个交叉点上的经历受到人际和结构性压迫系统的影响。研究发现,对于高危人群而言,远程视网膜筛查是比标准护理筛查更可取的策略。尚无研究基于理论基础评估DR筛查的经济公平性影响。

目的

本研究旨在解决在DR筛查的经济评估中运用交叉性理论方面的不足。我们提议对远程视网膜项目进行分布成本效益分析(DCEA)。

方法

本研究将采用演绎理论驱动的序贯多方法,包括两项研究:(1)一项改良德尔菲研究和(2)DCEA。德尔菲小组(患者伙伴、领域专家和决策者;N = 35 - 50)将为高危人群选择社会结构因素(如年龄、性别)以及健康最大化与公平之间的潜在权衡。该研究将以社会理论框架(交叉性理论)为指导,以理解社会结构因素对经济结果的影响。德尔菲小组选择的社会结构因素将被纳入经过验证的远程视网膜成本效益分析模型,该模型将作为DCEA的案例研究。

结果

我们已向大学健康网络研究伦理委员会提交了研究伦理委员会申请,预计2025年春季开始德尔菲研究的招募工作。我们预计2025年夏季开始模型工作,并在2026年初完成。

结论

德尔菲研究将有助于了解利益相关者认为哪些社会因素对于指导医疗服务获取方面的不公平是必要的。研究结果将提供与干预措施的净健康效益以及远程视网膜项目的健康公平性影响相关的信息,从而对远程视网膜项目进行更全面的评估,这对于旨在减轻健康不公平驱动因素的政策制定者和政府来说具有参考价值。我们预计这些驱动因素中的每一个都将引发关于决策影响的重要问题,而加拿大卫生技术评估机构(如加拿大药品管理局)可能尚未解决这些问题。这是加拿大第一项(1)由德尔菲小组选择用于DCEA的社会结构因素的研究,(2)将健康公平框架和社会结构因素在经济评估中的应用主流化的研究,(3)通过运用健康公平视角改进DR筛查项目的研究,以及(4)在项目评估的经济模型中对社会结构因素进行“从头开始”的整合并加以扩展和采用的研究。

国际注册报告识别码(IRRID):PRR1 - 10.2196/60488

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/8893a01078a8/resprot_v14i1e60488_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/22a5b546149c/resprot_v14i1e60488_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/4592e04b507c/resprot_v14i1e60488_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/f9ecb08e7f1a/resprot_v14i1e60488_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/8893a01078a8/resprot_v14i1e60488_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/22a5b546149c/resprot_v14i1e60488_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/4592e04b507c/resprot_v14i1e60488_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/f9ecb08e7f1a/resprot_v14i1e60488_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab41/12079062/8893a01078a8/resprot_v14i1e60488_fig4.jpg

相似文献

1
Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis.高危人群中的糖尿病视网膜病变筛查:分布成本效益分析方案
JMIR Res Protoc. 2025 Apr 30;14:e60488. doi: 10.2196/60488.
2
Impact of Intersecting Systems of Oppression on Diabetic Retinopathy Screening Among Those Who Identify as Women of Low Socioeconomic Status: Protocol for a Convergent Mixed Methods Study.交叉压迫系统对社会经济地位较低的女性糖尿病视网膜病变筛查的影响:一项混合方法收敛性研究方案
JMIR Res Protoc. 2021 Mar 5;10(3):e23492. doi: 10.2196/23492.
3
Tele-retina screening of diabetic retinopathy among at-risk populations: an economic analysis.远程视网膜筛查糖尿病视网膜病变高危人群:经济分析。
Can J Ophthalmol. 2020 Feb;55(1 Suppl 1):8-13. doi: 10.1016/j.jcjo.2019.06.008. Epub 2019 Aug 10.
4
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.关注公平:从英国社会角度出发,采用分布成本效益分析,评估 faricimab 治疗糖尿病黄斑水肿对公平性的影响。
Eye (Lond). 2024 Jul;38(10):1917-1925. doi: 10.1038/s41433-024-03043-y. Epub 2024 Mar 30.
5
Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.新加坡国家远程医疗糖尿病视网膜病变筛查计划的成本效益分析。
Ophthalmology. 2016 Dec;123(12):2571-2580. doi: 10.1016/j.ophtha.2016.08.021. Epub 2016 Oct 7.
6
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.非小细胞肺癌治疗的分布成本效益分析:综合分析及其关键驱动因素的说明。
Pharmacoeconomics. 2023 Aug;41(8):1011-1025. doi: 10.1007/s40273-023-01281-8. Epub 2023 Jun 9.
7
Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation.总体分布成本效益分析:一种用于卫生经济评估以指导资源分配的新工具。
Glob Health Res Policy. 2025 Apr 16;10(1):17. doi: 10.1186/s41256-025-00415-z.
8
Cost-Effectiveness of a Telemedicine Optometric-Based Assessment for Screening Diabetic Retinopathy in a Country with a Universal Public Health System.在一个拥有全民公共卫生系统的国家,基于远程医疗验光评估筛查糖尿病视网膜病变的成本效益分析
Telemed J E Health. 2024 Dec;30(12):2824-2833. doi: 10.1089/tmj.2024.0353. Epub 2024 Jul 31.
9
Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee.基于证据的加拿大糖尿病视网膜病变远程筛查指南:来自加拿大视网膜研究网络(CR2N)远程视网膜指导委员会的建议。
Can J Ophthalmol. 2020 Feb;55(1 Suppl 1):14-24. doi: 10.1016/j.jcjo.2020.01.001.
10
Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.评估退伍军人健康管理局的远程医疗在糖尿病视网膜病变筛查中的应用。
Ophthalmology. 2013 Dec;120(12):2604-2610. doi: 10.1016/j.ophtha.2013.06.029. Epub 2013 Sep 29.

本文引用的文献

1
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.非小细胞肺癌治疗的分布成本效益分析:综合分析及其关键驱动因素的说明。
Pharmacoeconomics. 2023 Aug;41(8):1011-1025. doi: 10.1007/s40273-023-01281-8. Epub 2023 Jun 9.
2
Intersectionality in quantitative research: A systematic review of its emergence and applications of theory and methods.定量研究中的交叉性:对其理论与方法的出现及应用的系统综述
SSM Popul Health. 2021 Apr 16;14:100798. doi: 10.1016/j.ssmph.2021.100798. eCollection 2021 Jun.
3
Impact of Intersecting Systems of Oppression on Diabetic Retinopathy Screening Among Those Who Identify as Women of Low Socioeconomic Status: Protocol for a Convergent Mixed Methods Study.
交叉压迫系统对社会经济地位较低的女性糖尿病视网膜病变筛查的影响:一项混合方法收敛性研究方案
JMIR Res Protoc. 2021 Mar 5;10(3):e23492. doi: 10.2196/23492.
4
A modified Delphi study to identify the features of high quality measurement plans for healthcare improvement projects.改良版德尔菲研究,旨在确定医疗改善项目高质量测量计划的特征。
BMC Med Res Methodol. 2020 Jan 14;20(1):8. doi: 10.1186/s12874-019-0886-6.
5
Tele-retina screening of diabetic retinopathy among at-risk populations: an economic analysis.远程视网膜筛查糖尿病视网膜病变高危人群:经济分析。
Can J Ophthalmol. 2020 Feb;55(1 Suppl 1):8-13. doi: 10.1016/j.jcjo.2019.06.008. Epub 2019 Aug 10.
6
Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.健康技术的综合分布成本效益分析。
Value Health. 2019 May;22(5):518-526. doi: 10.1016/j.jval.2019.03.006.
7
Introduction.引言。
Can J Diabetes. 2018 Apr;42 Suppl 1:S1-S5. doi: 10.1016/j.jcjd.2017.10.001.
8
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial.用于卫生政策评估的扩展成本效益分析:教程
Pharmacoeconomics. 2016 Sep;34(9):913-23. doi: 10.1007/s40273-016-0414-z.
9
Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.心血管疾病筛查以减轻心血管疾病负担:量化政策选项的微观模拟研究
BMJ. 2016 Jun 8;353:i2793. doi: 10.1136/bmj.i2793.
10
Distributional Cost-Effectiveness Analysis: A Tutorial.分布性成本效益分析:教程
Med Decis Making. 2016 Jan;36(1):8-19. doi: 10.1177/0272989X15583266. Epub 2015 Apr 23.